Attached files
| file | filename |
|---|---|
| 10-K - 10-K - PDL BIOPHARMA, INC. | pdli1231201710-kdoc.htm |
| EX-32.1 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex321.htm |
| EX-31.2 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex312.htm |
| EX-31.1 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex311.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PDL BIOPHARMA, INC. | pdli1231201710-kex231.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PDL BIOPHARMA, INC. | pdli1231201710-kex211.htm |
| EX-10.71 - EXHIBIT 10.71 - PDL BIOPHARMA, INC. | pdli1231201710-kex1071.htm |
Exhibit 12.1
PDL BIOPHARMA, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Unaudited)
For the Years Ended December 31, | ||||||||||||||||||||
(in thousands, except for ratios) | 2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||
Earnings: | ||||||||||||||||||||
Income before income taxes | $ | 401,876 | $ | 501,272 | $ | 530,138 | $ | 109,370 | $ | 184,527 | ||||||||||
Add: fixed charges | 24,931 | 39,274 | 27,123 | 18,330 | 20,507 | |||||||||||||||
Earnings | $ | 426,807 | $ | 540,546 | $ | 557,261 | $ | 127,700 | $ | 205,034 | ||||||||||
Fixed Charges: | ||||||||||||||||||||
Interest expense1 | $ | 24,871 | $ | 39,211 | $ | 27,059 | $ | 18,267 | $ | 20,221 | ||||||||||
Estimated interest portion of rent expense2 | 60 | 63 | 64 | 63 | 286 | |||||||||||||||
Fixed charges | $ | 24,931 | $ | 39,274 | $ | 27,123 | $ | 18,330 | $ | 20,507 | ||||||||||
Ratio of earnings to fixed charges | 17.12 | 13.76 | 20.55 | 6.97 | 10.00 | |||||||||||||||
_____________________________________
1 Interest expense includes amortization of debt discount and expenses.
2 Represents the estimated portion of operating lease rental expense that is considered by us to be representative of interest and amortization of discount related to indebtedness.